Viatris Inc (VTRS) - Total Assets
Based on the latest financial reports, Viatris Inc (VTRS) holds total assets worth $36.83 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Viatris Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Viatris Inc - Total Assets Trend (1985–2025)
This chart illustrates how Viatris Inc's total assets have evolved over time, based on quarterly financial data. Explore VTRS strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Viatris Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Viatris Inc's total assets of $36.83 Billion consist of 24.8% current assets and 75.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.6% |
| Accounts Receivable | $3.35 Billion | 9.0% |
| Inventory | $4.00 Billion | 10.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $15.10 Billion | 40.6% |
| Goodwill | $6.75 Billion | 18.2% |
Asset Composition Trend (1985–2025)
This chart illustrates how Viatris Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Viatris Inc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Viatris Inc's current assets represent 24.8% of total assets in 2025, a decrease from 79.5% in 1985.
- Cash Position: Cash and equivalents constituted 3.6% of total assets in 2025, down from 26.8% in 1985.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, an increase from 0.0% in 1985.
- Asset Diversification: The largest asset category is intangible assets at 40.6% of total assets.
Viatris Inc Competitors by Total Assets
Key competitors of Viatris Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA
|
India | Rs585.02 Billion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
|
China | CN¥10.37 Billion |
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
|
China | CN¥7.28 Billion |
|
Xeris Pharmaceuticals Inc
NASDAQ:XERS
|
USA | $392.01 Million |
|
Procter & Gamble Health Limited
NSE:PGHL
|
India | Rs8.94 Billion |
Viatris Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.60 | 1.68 | 1.16 |
| Quick Ratio | 1.03 | 0.97 | 0.72 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $4.11 Billion | $3.90 Billion | $1.62 Billion |
Viatris Inc - Advanced Valuation Insights
This section examines the relationship between Viatris Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.30 |
| Latest Market Cap to Assets Ratio | 0.50 |
| Asset Growth Rate (YoY) | -10.4% |
| Total Assets | $37.19 Billion |
| Market Capitalization | $18.68 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Viatris Inc's assets below their book value (0.50x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Viatris Inc's assets decreased by 10.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Viatris Inc (1985–2025)
The table below shows the annual total assets of Viatris Inc from 1985 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $37.19 Billion | -10.38% |
| 2024-12-31 | $41.50 Billion | -12.97% |
| 2023-12-31 | $47.69 Billion | -4.67% |
| 2022-12-31 | $50.02 Billion | -8.79% |
| 2021-12-31 | $54.84 Billion | -10.90% |
| 2020-12-31 | $61.55 Billion | +96.93% |
| 2019-12-31 | $31.26 Billion | -4.52% |
| 2018-12-31 | $32.73 Billion | -8.58% |
| 2017-12-31 | $35.81 Billion | +3.11% |
| 2016-12-31 | $34.73 Billion | +55.95% |
| 2015-12-31 | $22.27 Billion | +40.75% |
| 2014-12-31 | $15.82 Billion | +3.44% |
| 2013-12-31 | $15.29 Billion | +28.18% |
| 2012-12-31 | $11.93 Billion | +2.88% |
| 2011-12-31 | $11.60 Billion | +0.53% |
| 2010-12-31 | $11.54 Billion | +6.81% |
| 2009-12-31 | $10.80 Billion | +3.93% |
| 2008-12-31 | $10.39 Billion | -8.45% |
| 2007-12-31 | $11.35 Billion | +166.89% |
| 2006-12-31 | $4.25 Billion | +127.42% |
| 2005-12-31 | $1.87 Billion | -12.42% |
| 2004-12-31 | $2.14 Billion | +13.29% |
| 2003-12-31 | $1.89 Billion | +8.01% |
| 2002-12-31 | $1.75 Billion | +7.95% |
| 2001-12-31 | $1.62 Billion | +10.28% |
| 2000-12-31 | $1.47 Billion | +9.30% |
| 1999-12-31 | $1.34 Billion | +11.15% |
| 1998-12-31 | $1.21 Billion | +42.33% |
| 1997-12-31 | $847.80 Million | +9.03% |
| 1996-12-31 | $777.60 Million | +12.37% |
| 1995-12-31 | $692.00 Million | +26.69% |
| 1994-12-31 | $546.20 Million | +35.43% |
| 1993-12-31 | $403.30 Million | +14.87% |
| 1992-12-31 | $351.10 Million | +54.87% |
| 1991-12-31 | $226.70 Million | +33.67% |
| 1990-12-31 | $169.60 Million | +23.35% |
| 1989-12-31 | $137.50 Million | +22.01% |
| 1988-12-31 | $112.70 Million | +3.58% |
| 1987-12-31 | $108.80 Million | +35.49% |
| 1986-12-31 | $80.30 Million | +43.39% |
| 1985-12-31 | $56.00 Million | -- |
About Viatris Inc
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and … Read more